A rare presentation of enfortumab vedotin-induced toxic epidermal necrolysis

Andrea Francis; Antonio Jimenez; Swaminathan Sundaresan; Brent Kelly

doi:10.1016/j.jdcr.2020.10.020

A rare presentation of enfortumab vedotin-induced toxic epidermal necrolysis

JAAD Case Rep. 2020 Oct 23:7:57-59. doi: 10.1016/j.jdcr.2020.10.020. eCollection 2021 Jan.

Authors

Andrea Francis¹, Antonio Jimenez¹, Swaminathan Sundaresan², Brent Kelly²

Affiliations

¹ School of Medicine, The University of Texas Medical Branch, Galveston, Texas.
² Department of Dermatology, The University of Texas Medical Branch, Galveston, Texas.

No abstract available

Keywords: MMAE, monomethyl auristatin E; SCORTEN, score of toxic epidermal necrolysis; SJS, Stevens-Johnson syndrome; TEN, toxic epidermal necrolysis; enfortumab vedotin; general dermatology; medical dermatology; medical oncology; toxic epidermal necrolysis.

Publication types

Case Reports